On Monday the nation’s largest investors released information about their top holdings. And as the traders sifted through all the data, they found some surprises! Read More
Following are the week’s biggest winners and losers. Find out why shares of Dow Chemical and Massey Energy popped while Macy’s and Genzyme dropped. Read More
The Dollar Index is up for a second day in a row on Treasury Secretary Geithner's comments that the administration is committed to a stronger dollar. Despite the small gain, the US Dollar is now down over 15% since March relative to a basket of foreign currencies and many traders are betting it will continue its slide. Read More
This weekend, the US House of Representatives passed its version of health care reform and now awaits a version from the Senate. The debate has been heating up since earlier this summer when President Obama was pushing for legislation before the summer recess. Here are the biggest S&P Health Care gainers and losers over while the debate has waged on. Read More
Yesterday we passed the earnings season midpoint and now ~60% of the S&P 500 companies have reported earnings. Here's a look at which companies have had the biggest surprises so far... Read More
The best stock-market rally since 1935 has pushed 93% of the stocks in the S&P 500 above their 200-day moving averages. As upward momentum builds on the market, could some of the laggards be poised to pop? Read More
2,226 percent. That is the astronomical increase in shares of baby biopharma Vanda so far this year. And it's the prime historical example of "Biotech Takeouts and Breakouts" Bernstein's Geoffrey Porges uses in a sequel research note to clients he put out today. Read More